25 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35265524 | Effective Delivery of siRNA-Loaded Nanoparticles for Overcoming Oxaliplatin Resistance in Colorectal Cancer. | 2022 | 1 |
2 | 34533854 | FGF13 enhances resistance to platinum drugs by regulating hCTR1 and ATP7A via a microtubule-stabilizing effect. | 2021 Nov | 1 |
3 | 32006874 | The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents. | 2020 Mar 15 | 1 |
4 | 32570116 | The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer. | 2020 Sep | 1 |
5 | 31540259 | Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs. | 2019 Sep 13 | 2 |
6 | 31934199 | Expression of ATP7A in esophageal squamous cell carcinoma (ESCC) and its clinical significance. | 2019 | 3 |
7 | 29394468 | Copper efflux transporters ATP7A and ATP7B: Novel biomarkers for platinum drug resistance and targets for therapy. | 2018 Mar | 3 |
8 | 29970670 | ATP7B rs9535826 is associated with gastrointestinal toxicity of platinum-based chemotherapy in nonsmall cell lung cancer patients. | 2018 | 2 |
9 | 28164426 | Mechanisms of charge transfer in human copper ATPases ATP7A and ATP7B. | 2017 Apr | 1 |
10 | 28737129 | Association between polymorphisms in CTR1, CTR2, ATP7A, and ATP7B and platinum resistance in epithelial ovarian cancer. | 2017 Oct | 1 |
11 | 27014726 | Data showing the circumvention of oxaliplatin resistance by vatalanib in colon cancer. | 2016 Jun | 2 |
12 | 27877224 | The role of copper transporter ATP7A in platinum-resistance of esophageal squamous cell cancer (ESCC). | 2016 | 2 |
13 | 24038379 | miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A). | 2014 Jul | 3 |
14 | 24983998 | Platination of the copper transporter ATP7A involved in anticancer drug resistance. | 2014 Aug 21 | 1 |
15 | 25070243 | Cytotoxic effects of pyrrolidine dithiocarbamate in small-cell lung cancer cells, alone and in combination with cisplatin. | 2014 Oct | 1 |
16 | 25242165 | Biochemical characterization of P-type copper ATPases. | 2014 Oct 15 | 1 |
17 | 23751120 | Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification. | 2013 Aug 15 | 1 |
18 | 22304828 | Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). | 2012 Feb 3 | 5 |
19 | 22710939 | Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A. | 2012 Sep | 2 |
20 | 22966390 | Association of ATP7A expression and in vitro sensitivity to cisplatin in non-small cell lung cancer. | 2010 Sep | 2 |
21 | 19296535 | Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy. | 2009 Jun 15 | 1 |
22 | 19509135 | Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin. | 2009 Jul 1 | 1 |
23 | 20045993 | Genetic polymorphisms of copper- and platinum drug-efflux transporters ATP7A and ATP7B in Japanese cancer patients. | 2009 | 1 |
24 | 15213293 | Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. | 2004 Jul | 1 |
25 | 14676106 | Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. | 2003 Dec 1 | 1 |